Matches in SemOpenAlex for { <https://semopenalex.org/work/W301932005> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W301932005 endingPage "147" @default.
- W301932005 startingPage "143" @default.
- W301932005 abstract "Overexpession of EGFR has been reported in a variety of human cancers and serves as a target for diagnosis and therapy. In the case of breast cancer, about 48% EGFR and have poor clinical prognosis. Besides the prognostic factors like tumor size, nodal status, histological grade etc., which are significant in the management of breast cancer, EGFR level might also serve as an additional parameter. Immunocytochemical assay has been extensively used to study the expression of EGFR in various cancers. We have generated a panel of monoclonal antibodies against human EGFR with a view to evaluate their application for the diagnosis and therapy of these cancers. In the present study, an EIA has been developed using 2 monoclonal antibodies against hEGFR designated as CIBCNSH3 as the capture antibody and CIBCRGC1 as the detector antibody. EGFR isolated from MDA MB 468, a human breast carcinoma cell line, with high expression of EGFR and purified by conA affinity chromatography and HPLC has been used to develop the EIA procedure. Sera samples of 150 healthy women donors, of 300 breast cancer patients with different histological types of malignancies and of various other types of cancers have been analyzed. The control women had a range for serum EGFR level of 7-162 fmol/ml, whereas the 300 breast cancer patients studied had a range of 126-1587 fmol/ml with a cut off value of 180 fmol/ml. It is interesting to note that 67.5% of breast cancer patients had elevated levels of circulating EGFR. These results might suggest that serum EGFR level can be used as prognostic marker for breast cancer. The serum EGFR level will be compared with disease free interval and patient survival." @default.
- W301932005 created "2016-06-24" @default.
- W301932005 creator A5041386455 @default.
- W301932005 creator A5066268521 @default.
- W301932005 creator A5067477221 @default.
- W301932005 date "2001-12-31" @default.
- W301932005 modified "2023-09-30" @default.
- W301932005 title "Enzyme immunoassay of human Epidermal Growth Factor Receptor (hEGFR)" @default.
- W301932005 cites W1462047702 @default.
- W301932005 cites W1964735365 @default.
- W301932005 cites W1967726190 @default.
- W301932005 cites W1995434322 @default.
- W301932005 cites W2012764774 @default.
- W301932005 cites W2059048157 @default.
- W301932005 cites W2081069364 @default.
- W301932005 cites W2100837269 @default.
- W301932005 cites W2140858291 @default.
- W301932005 doi "https://doi.org/10.3233/hab-2001-103-406" @default.
- W301932005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11847425" @default.
- W301932005 hasPublicationYear "2001" @default.
- W301932005 type Work @default.
- W301932005 sameAs 301932005 @default.
- W301932005 citedByCount "18" @default.
- W301932005 countsByYear W3019320052012 @default.
- W301932005 countsByYear W3019320052014 @default.
- W301932005 countsByYear W3019320052015 @default.
- W301932005 countsByYear W3019320052020 @default.
- W301932005 crossrefType "journal-article" @default.
- W301932005 hasAuthorship W301932005A5041386455 @default.
- W301932005 hasAuthorship W301932005A5066268521 @default.
- W301932005 hasAuthorship W301932005A5067477221 @default.
- W301932005 hasConcept C121608353 @default.
- W301932005 hasConcept C126322002 @default.
- W301932005 hasConcept C142724271 @default.
- W301932005 hasConcept C143998085 @default.
- W301932005 hasConcept C159654299 @default.
- W301932005 hasConcept C163864487 @default.
- W301932005 hasConcept C203014093 @default.
- W301932005 hasConcept C2777546739 @default.
- W301932005 hasConcept C2779438470 @default.
- W301932005 hasConcept C2780420688 @default.
- W301932005 hasConcept C502942594 @default.
- W301932005 hasConcept C530470458 @default.
- W301932005 hasConcept C542903549 @default.
- W301932005 hasConcept C71924100 @default.
- W301932005 hasConceptScore W301932005C121608353 @default.
- W301932005 hasConceptScore W301932005C126322002 @default.
- W301932005 hasConceptScore W301932005C142724271 @default.
- W301932005 hasConceptScore W301932005C143998085 @default.
- W301932005 hasConceptScore W301932005C159654299 @default.
- W301932005 hasConceptScore W301932005C163864487 @default.
- W301932005 hasConceptScore W301932005C203014093 @default.
- W301932005 hasConceptScore W301932005C2777546739 @default.
- W301932005 hasConceptScore W301932005C2779438470 @default.
- W301932005 hasConceptScore W301932005C2780420688 @default.
- W301932005 hasConceptScore W301932005C502942594 @default.
- W301932005 hasConceptScore W301932005C530470458 @default.
- W301932005 hasConceptScore W301932005C542903549 @default.
- W301932005 hasConceptScore W301932005C71924100 @default.
- W301932005 hasIssue "3-4" @default.
- W301932005 hasLocation W3019320051 @default.
- W301932005 hasLocation W3019320052 @default.
- W301932005 hasOpenAccess W301932005 @default.
- W301932005 hasPrimaryLocation W3019320051 @default.
- W301932005 hasRelatedWork W1943797027 @default.
- W301932005 hasRelatedWork W1986429294 @default.
- W301932005 hasRelatedWork W1999686187 @default.
- W301932005 hasRelatedWork W2009919126 @default.
- W301932005 hasRelatedWork W2030675209 @default.
- W301932005 hasRelatedWork W2059375575 @default.
- W301932005 hasRelatedWork W2073840950 @default.
- W301932005 hasRelatedWork W2095550968 @default.
- W301932005 hasRelatedWork W2273954425 @default.
- W301932005 hasRelatedWork W2277732534 @default.
- W301932005 hasVolume "10" @default.
- W301932005 isParatext "false" @default.
- W301932005 isRetracted "false" @default.
- W301932005 magId "301932005" @default.
- W301932005 workType "article" @default.